SUTTER DAVIS HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $390K
- Transactions
- 122
- Companies
- 25
- Average per transaction
- $3,199
Who reported the payments
| Genentech, Inc. | $117,034 |
| Stryker | $63,862 |
| Pfizer | $45,134 |
| Abbott | $41,989 |
| Ethicon Endo-surgery Inc. | $19,652 |
| Shockwave Medical, Inc | $16,745 |
| Boston Scientific | $15,868 |
| AbbVie | $15,000 |
| Microline Surgical Inc | $11,180 |
| Astrazeneca UK Limited | $11,105 |
| Olympus America Inc. | $8,821 |
| Biomarin Pharmaceutical Inc. | $3,999 |
| Novartis | $3,300 |
| AstraZeneca | $3,213 |
| MDD US Operations, LLC | $2,500 |
| Genentech USA, Inc. | $2,500 |
| Medline Industries LP | $2,391 |
| Medivation LLC. | $2,258 |
| Smith+Nephew | $1,350 |
| Philips North America LLC | $800 |
| Puma Biotechnology, Inc. | $750 |
| Aesculap, Inc. | $576 |
| Amgen | $96 |
| Bio-rad Laboratories, Inc. | $94 |
| Boehringer Ingelheim | $26 |